XML 93 R80.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 08, 2020
Jul. 19, 2019
May 03, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Stockholders Equity Note Disclosure [Line Items]            
Common stock, shares issued 1,725,000 1,587,000 3,144,531 54,760,837 52,078,258  
Common stock issue price per share $ 181.00 $ 87.00 $ 64.00      
Exercised number of shares       340,546    
Net proceeds from public offering $ 297,800 $ 131,100 $ 189,600 $ 297,775 $ 320,713  
Stock-based compensation expense       $ 17,007 $ 12,847 $ 10,192
Stock options, outstanding       696,711 957,559  
Aggregate intrinsic value of stock options exercised       $ 36,600 $ 5,500 $ 5,300
Weighted average grant date fair value of share-based awards granted       $ 53.06 $ 31.27 $ 18.90
Total fair value of stock options vested       $ 2,800 $ 3,100 $ 2,300
Total unrecognized compensation cost       $ 46,700    
Unrecognized compensation cost, weighted average remaining requisite service period       3 years 6 months 18 days    
Number of unvested options and restricted stock units       1,853,028    
2018 Plan            
Stockholders Equity Note Disclosure [Line Items]            
Common stock shares reserved for Issuance           2,778,000
Incentive options, vesting period       2,306,943    
Employee Stock Option | Minimum | Vest Over Three Year            
Stockholders Equity Note Disclosure [Line Items]            
Incentive options, vesting percentage       20.00%    
Employee Stock Option | Maximum | Vest Over Five Year            
Stockholders Equity Note Disclosure [Line Items]            
Incentive options, vesting percentage       33.00%    
Option To Purchase Common Stock            
Stockholders Equity Note Disclosure [Line Items]            
Stock options, outstanding       696,711 957,559 998,226
Restricted Stock Units (RSUs)            
Stockholders Equity Note Disclosure [Line Items]            
Restricted stock units, outstanding       665,540 734,984 705,413
Closing price of common stock       $ 191.63    
Aggregate intrinsic value of restricted stock units vested       $ 28,300 $ 17,500 $ 6,200
Weighted average grant date fair value of restricted stock units granted       $ 109.69 $ 49.68 $ 30.30
Total grant date fair value of restricted stock units vested       $ 10,800 $ 8,500 $ 4,600
Underwriters | Common Stock            
Stockholders Equity Note Disclosure [Line Items]            
Exercised number of shares 225,000 207,000 410,156